![Benjamin McGraw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin McGraw
Presidente presso
EVOMMUNE, INC.
Patrimonio netto: - $ in data 31/07/2026
Profilo
Benjamin F.
McGraw is currently Chairman & Chief Executive Officer at TheraVida, Inc. since 2014, Chairman & Chief Executive Officer at Auration Biotech, Inc. since 2014, Executive Chairman at Trefoil Therapeutics, Inc. since 2017, Chairman at Evommune, Inc. since 2020, Executive Chairman at Perfuse Therapeutics, Inc., and Venture Partner at Sanderling Management CO LLC.
Former roles include Chairman, President, CEO, CFO & CAO at Valentis, Inc. from 1994 to 2007, Executive Chairman at TRF Pharma, Inc., Chairman at Vaneltix Pharma, Inc. from 1994 to 2009, Director at ISTA Pharmaceuticals, Inc. from 2000 to 2002, Independent Director at Aerie Pharmaceuticals, Inc. in 2022, Vice President-Corporate Development at Allergan, Inc., Vice President-Development at Marion Merrell Dow, Inc. and Marion Laboratories from 1978 to 1989, Fund Manager & Equity Analyst at Carerra Capital Management, Inc., and Managing Member at Long Shadows Asset Management LLC from 2006 to 2014.
Education includes undergraduate and doctorate degrees from The University of Tennessee Health Science Center.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
EVOMMUNE, INC. -.--% | 02/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Benjamin McGraw
| Società | Posizione | Inizio |
|---|---|---|
| EVOMMUNE, INC. | Presidente | 01/10/2020 |
TheraVida, Inc.
 TheraVida, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products that improve the lives of patients | Amministratore Delegato | 01/01/2011 |
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Ventures invests in companies located in the United States. The firm participates in seed and early-stage capital transactions. It focuses on sectors such as biomedical and emerging technology. | Investitore di Private Equity | - |
Trefoil Therapeutics, Inc.
 Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases | Presidente | 01/01/2017 |
Auration Biotech, Inc.
 Auration Biotech, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of diseases of ear, nose and throat | Amministratore Delegato | 01/01/2014 |
Perfuse Therapeutics, Inc.
 Perfuse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to improve blood flow in retina and reduce blindness | Presidente | - |
Precedenti posizioni note di Benjamin McGraw
| Società | Posizione | Fine |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/03/2022 |
Long Shadows Asset Management LLC
 Long Shadows Asset Management LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01/01/2014 |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients with urological ailments | Presidente | 21/07/2009 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Benjamin McGraw
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Valentis, Inc.
 Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets ophthalmic pharmaceutical products | Health Technology |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Ventures invests in companies located in the United States. The firm participates in seed and early-stage capital transactions. It focuses on sectors such as biomedical and emerging technology. | Finance |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
TheraVida, Inc.
TheraVida, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products that improve the lives of patients | Health Technology |
TRF Pharma, Inc.
 TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Marion Merrell Dow, Inc.
 Marion Merrell Dow, Inc. Pharmaceuticals: MajorHealth Technology Brand name drug company | Health Technology |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients with urological ailments | Health Technology |
Marion Laboratories
 Marion Laboratories Medical DistributorsDistribution Services Wholesales drugs | Distribution Services |
Carerra Capital Management, Inc. | |
Long Shadows Asset Management LLC
Long Shadows Asset Management LLC Investment ManagersFinance Provides investment advice | Finance |
The University of Tennessee Health Science Center
 The University of Tennessee Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auration Biotech, Inc.
Auration Biotech, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of diseases of ear, nose and throat | Health Technology |
Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases | Health Technology |
Perfuse Therapeutics, Inc.
Perfuse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to improve blood flow in retina and reduce blindness | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
